A site where you can find recommended contractors for non-clinical testing｜effical " Non-Clinical CROs and Agencies " Accutest Research Laboratories

Accutest Research Laboratories

Accutest Research Laboratories is a CRO based in India that offers a wide range of development support, from preclinical to clinical trials. They can also conduct preclinical studies in their own facilities, with their integrated service system, including analysis and regulatory compliance, being a key strength. This article introduces the features of Accutest Research Laboratories' preclinical studies.

Features of Accutest Research Laboratories' Contract Non-Clinical Testing Services

Advanced testing techniques, including MoA analysis

Our strengths lie in advanced testing techniques that support Mechanism of Action (MoA) analysis. While general non-clinical studies often focus on superficial evaluations like efficacy and toxicity, our company offersAnalysis is possible to clarify which molecular pathways or physiological mechanisms candidate compounds act on.In the early stages of drug discovery, we support target validation and the acquisition of scientific evidence to support drug efficacy. Furthermore, our ability to elucidate complex mechanisms of action, which is crucial for the development of biologics and advanced pharmaceuticals, contributes to reducing development risks and facilitating a smooth transition to subsequent studies.

High reliability through GLP/GCLP and international regulatory compliance

Operational structure compliant with GLP (Good Laboratory Practice) and GCLP (Good Clinical Laboratory Practice)and is strong in ensuring data reliability and reproducibility. These standards demand strict quality control from test planning, execution, recording, and reporting, ensuring the eligibility of the submission documents to regulatory authorities. They also comply with the standards of major international regulatory agencies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency, and the World Health Organization, and have successfully passed numerous inspections. The non-clinical data acquired can be directly utilized for global development and approval applications.

Powerful bioanalytical platform centered on LC-MS/MS

We have an advanced bioanalysis platform centered on LC-MS/MS (Liquid Chromatography-Mass Spectrometry), excelling in precise quantitative analysis for non-clinical studies.Utilizing a large number of LC-MS/MS instrumentsThis enables highly sensitive and selective measurements, allowing for the understanding of the pharmacokinetics of trace amounts of drugs and metabolites. Another feature is our extensive portfolio of validated analytical methods, ensuring rapid assay setup and highly reproducible data acquisition. We can accommodate not only small molecule drugs but also biopharmaceuticals and immunogenicity testing, offering flexibility to meet the increasingly complex needs of drug development. We have established a system capable of providing reliable bioanalysis essential for bridging non-clinical to clinical stages.

Integrated support from non-clinical to clinical and regulatory submission

Accutest Research Laboratories' strengths are,An integrated CRO that can provide consistent support from preclinical studies to clinical trials and regulatory submission. maintain a system that bridges preclinical efficacy, safety, and pharmacokinetic data to subsequent clinical trial designs, contributing to overall development efficiency. We also have experience in dealing with regulatory authorities such as the U.S. Food and Drug Administration and the European Medicines Agency, allowing us to establish strategies with an eye toward regulatory submission from the trial planning stage. By ensuring data integrity and regulatory compliance between each phase, we reduce development risks and accelerate the time to approval. Our comprehensive support, which goes beyond mere contract research, is a key advantage.

An example of a disease model held by Accutest Research Laboratories

The pathological models I possess are not listed on the official website.

Accutest Research Laboratories Non-clinical Study Cases

Information on non-clinical study examples was not available on the official website.

Accutest Research Laboratories Company Information

Address	A-77, Thane - Belapur Rd, TTC Industrial Area, MIDC Industrial Area, Kopar Khairane, Mumbai, Maharashtra 400709, India
Tel	+91-22 2778 0720
Website	https://www.accutestglobal.com/

3 Recommended Contract Research Organizations for Non-Clinical Studies
— by Target goal and Expertise

In drug discovery, the quality and efficiency of non-clinical studies have a direct impact on clinical success rates, development costs, and overall length of time required in R&D. In recent years, there has been more demand for clinically relevant data, globally accepted reliability, and accurate early-stage screening. Thus, it is more important than ever to select the right CRO (Contract Research Organization) for strategic approach.
In this article, we highlight three CROs with proven technical capabilities, expertise, and long standing track records. These are our TOP 3 choices based on their capabilities and the specific target goals of the researchers for their non-clinical studies.

Pharmacology (Efficacy) Studies
Replicate unknown pathological models and
Discovery to clinically oriented drug evaluation

SMC Laboratories, Inc.

Reference: SMC Laboratories, Inc. official website (https://www.smccro-lab.com/jp/)

SMC Laboratories, Inc. has established a disease models using patented mouse technologies. The company has established proprietary pathological models—particularly in liver disease and fibrosis—and continues to expand their approach across a wide range of models in cancer, inflammation, and metabolic diseases.
From exploratory research to clinically oriented efficacy evaluation, SMC offers customized study designs, dosing strategies, and evaluation analysis tailored to each project. Their collaborative approachallows researchers to discuss and refine study plans together with SMC’s expert scientists.
With flexible small-scale study options and strong technical support, SMC Laboratories, Inc. is an ideal partner for start-ups, biotech ventures, and academic institutions alike.

Consult study design and disease model development
with SMC Laboratories, Inc.

Consult SMC Laboratories
Call us

Safety Studies
Comprehensive Safety Evaluation for FIH Applications

Labcorp Holdings Inc.
(Labcorp Drug Development)

Reference: Labcorp Holdings Inc. official website (https://jp.labcorp.com/)

Labcorp Holdings Inc. provides a fully integrated GLP testing system aligned with international regulatory standards, including FDA, EMA, and PMDA requirements. All studies are conducted under ICH-compliant quality assurance, making it ready for data submission.
The company has extensive expertise in long-term toxicity studies such as Segment I–III reproductive and carcinogenicity studies, as well as 2-year chronic toxicity assessments.
Labcorp Holdings Inc.’s comprehensive approach enables sponsors to efficiently outsource the entire preclinical package from toxicology, toxicokinetic (TK), and safety pharmacology study design to execution. This accelerates a path to First-in-Human (FIH) trials. For most of the global drug developers, this all-in-one service structure minimizes cost, risk, and expedite the time before advancing to clinical phase.

Consult Labcorp Holdings Inc.
Discuss GLP/ICH-compliant study design for your FIH submission.

To labcorp.
Call us

Pharmacokinetic (PK/PD) Studies
High-Precision Bioanalysis for Clinically Predictive PK/PD Evaluation

PhoenixBio Co., Ltd.

Source: PhoenixBio Co., Ltd. Official Website (https://phoenixbio.co.jp/)

PhoenixBio Co., Ltd.offers pharmacokinetic and hepatic metabolism studies using their proprietary PXB-mouse®, a humanized-liver chimeric mouse model. This platform enables the acquisition of data with high clinical correlation in ADME, drug–to-drug interaction studies, bridging the gap between preclinical and clinical stages.
With advanced LC-MS/MS-based bioanalysis, PhoenixBio Co., Ltd. provides aseamless workflow from plasma concentration measurement and metabolite identification to quantitative validation.
The company offersan integrated evaluation analysiscovering pharmacokinetics, hepatotoxicity, and safety with flexibility to accommodate complex modalities such as oligonucleotide and middle-molecule therapeutics. For compounds where hepatic metabolism is a development bottleneck—or where quantitative, reproducible exposure data are critical—PhoenixBio Co., Ltd. delivers unmatched analytical precision and consistency.

Consult Phoenix Bio for PK/PD analysis with a clinical focus

Phoenix Bio.
Call us